{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:40:32Z","timestamp":1780508432404,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"DOI":"10.1007\/s10554-022-02676-y","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T16:16:24Z","timestamp":1657728984000},"page":"2081-2088","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tc-99m pyrophosphate scintigraphy for cardiac amyloidosis: concordance between planar and SPECT\/CT imaging"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1458-9392","authenticated-orcid":false,"given":"Nazim","family":"Coskun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5841-8563","authenticated-orcid":false,"given":"M. Oguz","family":"Kartal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8855-3755","authenticated-orcid":false,"given":"A. Sinem","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3478-9292","authenticated-orcid":false,"given":"Omac","family":"Tufekcioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9142-8752","authenticated-orcid":false,"given":"Elif","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"2676_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/HCI.0000000000000029","volume":"14","author":"S Dorbala","year":"2021","unstructured":"Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA et al (2021) ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2\u2014evidence base and standardized methods of imaging. Circ Cardiovasc Imaging 14:e000029. https:\/\/doi.org\/10.1161\/HCI.0000000000000029","journal-title":"Circ Cardiovasc Imaging"},{"key":"2676_CR2","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00259-018-4013-4","volume":"45","author":"G Treglia","year":"2018","unstructured":"Treglia G, Glaudemans A, Bertagna F, Hazenberg BPC, Erba PA, Giubbini R et al (2018) Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis. Eur J Nucl Med Mol Imaging 45:1945\u20131955. https:\/\/doi.org\/10.1007\/s00259-018-4013-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2676_CR3","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A et al (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133:2404\u20132412. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.021612","journal-title":"Circulation"},{"key":"2676_CR4","unstructured":"Dorbala S, Bokhari S, Miller E, Bullock-Palmer R, Soman P, Thompson R (2019) ASNC practice points: 99m-technetium-pyrophosphate imaging for transthyretin cardiac amyloidosis. American Society of Nuclear Cardiology"},{"key":"2676_CR5","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s12350-020-02455-z","volume":"28","author":"S Dorbala","year":"2021","unstructured":"Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA et al (2021) Addendum to ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2\u2014evidence base and standardized methods of imaging. J Nucl Cardiol 28:1769\u20131774. https:\/\/doi.org\/10.1007\/s12350-020-02455-z","journal-title":"J Nucl Cardiol"},{"key":"2676_CR6","unstructured":"\u00c7avu\u015fo\u011flu Y, \u00d6zpelit E, \u00c7elik A, \u0130kitimur B, Kay\u0131k\u00e7\u0131o\u011flu M, Tokg\u00f6zo\u011flu L et al (2019) Kardiyak amiloidoz: Tan\u0131 ve tedavide yenilikler"},{"key":"2676_CR7","doi-asserted-by":"publisher","first-page":"e006075","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","volume":"12","author":"MS Maurer","year":"2019","unstructured":"Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M et al (2019) Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis. Circ Heart Fail 12:e006075","journal-title":"Circ Heart Fail"},{"key":"2676_CR8","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","volume":"46","author":"E Perugini","year":"2005","unstructured":"Perugini E, Guidalotti PL, Salvi F, Cooke RM, Pettinato C, Riva L et al (2005) Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 46:1076\u20131084. https:\/\/doi.org\/10.1016\/j.jacc.2005.05.073","journal-title":"J Am Coll Cardiol"},{"key":"2676_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/joim.12585","volume":"281","author":"OB Suhr","year":"2017","unstructured":"Suhr OB, Lundgren E, Westermark P (2017) One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition. J Intern Med 281:337\u2013347. https:\/\/doi.org\/10.1111\/joim.12585","journal-title":"J Intern Med"},{"key":"2676_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3109\/13506129.2015.1072089","volume":"22","author":"A Galat","year":"2015","unstructured":"Galat A, Rosso J, Guellich A, Van Der Gucht A, Rappeneau S, Bodez D et al (2015) Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis. Amyloid 22:210\u2013220. https:\/\/doi.org\/10.3109\/13506129.2015.1072089","journal-title":"Amyloid"},{"key":"2676_CR11","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","volume":"18","author":"DF Hutt","year":"2017","unstructured":"Hutt DF, Fontana M, Burniston M, Quigley AM, Petrie A, Ross JC et al (2017) Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid. Eur Heart J Cardiovasc Imaging 18:1344\u20131350. https:\/\/doi.org\/10.1093\/ehjci\/jew325","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2676_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s12350-020-02503-8","volume":"28","author":"J Gerber","year":"2021","unstructured":"Gerber J, Miller EJ (2021) Optimal interpretation of Tc-99m PYP in 2020: avoiding the million-dollar mistake. J Nucl Cardiol 28:503\u2013506. https:\/\/doi.org\/10.1007\/s12350-020-02503-8","journal-title":"J Nucl Cardiol"},{"key":"2676_CR13","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1007\/s12350-020-02205-1","volume":"27","author":"C Regis","year":"2020","unstructured":"Regis C, Harel F, Martineau P, Gregoire J, Abikhzer G, Juneau D et al (2020) Tc-99m-pyrophosphate scintigraphy for the diagnosis of ATTR cardiac amyloidosis: comparison of quantitative and semi-quantitative approaches. J Nucl Cardiol 27:1808\u20131815. https:\/\/doi.org\/10.1007\/s12350-020-02205-1","journal-title":"J Nucl Cardiol"},{"key":"2676_CR14","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","volume":"1","author":"A Castano","year":"2016","unstructured":"Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R et al (2016) Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol 1:880\u2013889","journal-title":"JAMA Cardiol"},{"key":"2676_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12350-016-0610-4","volume":"25","author":"S Bokhari","year":"2018","unstructured":"Bokhari S, Morgenstern R, Weinberg R, Kinkhabwala M, Panagiotou D, Castano A et al (2018) Standardization of (99m)technetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis. J Nucl Cardiol 25:181\u2013190. https:\/\/doi.org\/10.1007\/s12350-016-0610-4","journal-title":"J Nucl Cardiol"},{"key":"2676_CR16","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1007\/s12350-020-02139-8","volume":"27","author":"BW Sperry","year":"2020","unstructured":"Sperry BW, Burgett E, Bybee KA, McGhie AI, O\u2019Keefe JH, Saeed IM et al (2020) Technetium pyrophosphate nuclear scintigraphy for cardiac amyloidosis: imaging at 1 vs 3 hours and planar vs SPECT\/CT. J Nucl Cardiol 27:1802\u20131807. https:\/\/doi.org\/10.1007\/s12350-020-02139-8","journal-title":"J Nucl Cardiol"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-022-02676-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-022-02676-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-022-02676-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T17:33:20Z","timestamp":1695144800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-022-02676-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":16,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["2676"],"URL":"https:\/\/doi.org\/10.1007\/s10554-022-02676-y","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"assertion":[{"value":"23 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional and\/or National Research Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study. Approval was granted by the Local Ethics Committee (Approval No. E2-21-1168).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}